218 related articles for article (PubMed ID: 3624946)
1. Regulation of smooth muscle proliferation by heparin in vitro and in vivo.
Clowes AW; Clowes MM
Int Angiol; 1987; 6(1):45-51. PubMed ID: 3624946
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans.
Majack RA; Clowes AW
J Cell Physiol; 1984 Mar; 118(3):253-6. PubMed ID: 6699099
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.
Wiernicki TR; Bean JS; Dell C; Williams A; Wood D; Kauffman RF; Singh JP
J Pharmacol Exp Ther; 1996 Sep; 278(3):1452-9. PubMed ID: 8819533
[TBL] [Abstract][Full Text] [Related]
4. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
[TBL] [Abstract][Full Text] [Related]
5. [Development of fibromuscular proliferation and atheroma in vitro as a therapeutic model].
Betz E; Roth D; Wolburg-Buchholz K
Vasa Suppl; 1990; 30():51-5. PubMed ID: 2075588
[No Abstract] [Full Text] [Related]
6. TAS-301, an inhibitor of smooth muscle cell migration and proliferation, inhibits intimal thickening after balloon injury to rat carotid arteries.
Muranaka Y; Yamasaki Y; Nozawa Y; Terakawa H; Tanahashi Y; Oda N; Satoh A; Asao T; Miyake H; Matsuura N
J Pharmacol Exp Ther; 1998 Jun; 285(3):1280-6. PubMed ID: 9618434
[TBL] [Abstract][Full Text] [Related]
7. Effects of anti-atherosclerotic substances on smooth muscle cell migration and proliferation analyzed by time-lapse video microscopy.
Grünwald J
Int Angiol; 1987; 6(1):59-64. PubMed ID: 3624949
[TBL] [Abstract][Full Text] [Related]
8. Factors controlling growth of arterial cells following injury.
Reidy MA; Jackson CL
Toxicol Pathol; 1990; 18(4 Pt 1):547-53. PubMed ID: 2091233
[TBL] [Abstract][Full Text] [Related]
9. Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins.
Hämmerle H; Betz E; Herr D
Vasa; 1991; 20(3):207-15. PubMed ID: 1659056
[TBL] [Abstract][Full Text] [Related]
10. [Effect of dihematoporphyrin derivatives on cultivated human smooth muscle cells from normal and atherosclerotic vascular segments-- Overview of results and implications for photodynamic therapy].
Dartsch PC; Betz E; Ischinger T
Z Kardiol; 1991 Jan; 80(1):6-14. PubMed ID: 1827935
[TBL] [Abstract][Full Text] [Related]
11. Early morphological changes of vessels in an experimental model system.
Takács E; Jellinek H
Int Angiol; 1987; 6(1):7-19. PubMed ID: 2442274
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin.
Orlandi A; Ropraz P; Gabbiani G
Exp Cell Res; 1994 Oct; 214(2):528-36. PubMed ID: 7925646
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of propylthiouracil independent of its hypothyroid effect on atherogenesis in cholesterol-fed rabbits: PTEN induction and inhibition of vascular smooth muscle cell proliferation and migration.
Chen WJ; Lin KH; Lai YJ; Yang SH; Pang JH
Circulation; 2004 Sep; 110(10):1313-9. PubMed ID: 15326060
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin.
Clowes AW; Clowes MM
Lab Invest; 1985 Jun; 52(6):611-6. PubMed ID: 4040189
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells.
Castellot JJ; Beeler DL; Rosenberg RD; Karnovsky MJ
J Cell Physiol; 1984 Sep; 120(3):315-20. PubMed ID: 6746751
[TBL] [Abstract][Full Text] [Related]
16. [The dynamics of blood vessel wall changes in the pathogenesis of arteriosclerosis].
Kling D; Holzschuh T; Betz E
Vasa Suppl; 1988; 23():11-4. PubMed ID: 3206328
[No Abstract] [Full Text] [Related]
17. Sodium spirulan as a potent inhibitor of arterial smooth muscle cell proliferation in vitro.
Kaji T; Okabe M; Shimada S; Yamamoto C; Fujiwara Y; Lee JB; Hayashi T
Life Sci; 2004 Mar; 74(19):2431-9. PubMed ID: 14998720
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human vascular smooth muscle cell migration and proliferation by beta-cyclodextrin tetradecasulfate.
Okada SS; Kuo A; Muttreja MR; Hozakowska E; Weisz PB; Barnathan ES
J Pharmacol Exp Ther; 1995 May; 273(2):948-54. PubMed ID: 7752099
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen and atherosclerosis.
Smith EB
Wien Klin Wochenschr; 1993; 105(15):417-24. PubMed ID: 8379153
[TBL] [Abstract][Full Text] [Related]
20. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
